Recombinant human erythropoietin injection (CHO cells) is clinically used for anemia caused by renal insufficiency, including hemodialysis, peritoneal dialysis and non dialysis patients with chronic renal failure.
This report contains market size and forecasts of Recombinant Human Erythropoietin Injection in global, including the following market information:
Global Recombinant Human Erythropoietin Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Recombinant Human Erythropoietin Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Recombinant Human Erythropoietin Injection companies in 2022 (%)
The global Recombinant Human Erythropoietin Injection market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
0.3ml Branch Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Erythropoietin Injection include Roche, LG Chem, Kexing Biopharm, 3SBio Group, Harbin Pharmaceutical Group Holding, Dong-E-E-Jiao, Humanwell Healthcare, Ncpc Genetech Biotechnology and Shandong E-hua Biotech Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Erythropoietin Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Erythropoietin Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Erythropoietin Injection Market Segment Percentages, by Type, 2022 (%)
0.3ml Branch
0.6ml Branch
1ml Branch
Others
Global Recombinant Human Erythropoietin Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Erythropoietin Injection Market Segment Percentages, by Application, 2022 (%)
Renal Failure Anemia
Non Renal Anemia
Global Recombinant Human Erythropoietin Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Recombinant Human Erythropoietin Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Erythropoietin Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Erythropoietin Injection revenues share in global market, 2022 (%)
Key companies Recombinant Human Erythropoietin Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Recombinant Human Erythropoietin Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
LG Chem
Kexing Biopharm
3SBio Group
Harbin Pharmaceutical Group Holding
Dong-E-E-Jiao
Humanwell Healthcare
Ncpc Genetech Biotechnology
Shandong E-hua Biotech Pharmaceutical
Intas Pharmaceuticals
PeproTech
WELLONA PHARMA
SI HUAN SHENG WU
Shanxi Weiqidaguangming Pharmaceutical
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Erythropoietin Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Recombinant Human Erythropoietin Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Erythropoietin Injection Overall Market Size
2.1 Global Recombinant Human Erythropoietin Injection Market Size: 2022 VS 2030
2.2 Global Recombinant Human Erythropoietin Injection Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Recombinant Human Erythropoietin Injection Sales: 2018-2030
3 Company Landscape
3.1 Top Recombinant Human Erythropoietin Injection Players in Global Market
3.2 Top Global Recombinant Human Erythropoietin Injection Companies Ranked by Revenue
3.3 Global Recombinant Human Erythropoietin Injection Revenue by Companies
3.4 Global Recombinant Human Erythropoietin Injection Sales by Companies
3.5 Global Recombinant Human Erythropoietin Injection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Recombinant Human Erythropoietin Injection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Recombinant Human Erythropoietin Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Erythropoietin Injection Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Erythropoietin Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Erythropoietin Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Recombinant Human Erythropoietin Injection Market Size Markets, 2022 & 2030
4.1.2 0.3ml Branch
4.1.3 0.6ml Branch
4.1.4 1ml Branch
4.1.5 Others
4.2 By Type - Global Recombinant Human Erythropoietin Injection Revenue & Forecasts
4.2.1 By Type - Global Recombinant Human Erythropoietin Injection Revenue, 2018-2023
4.2.2 By Type - Global Recombinant Human Erythropoietin Injection Revenue, 2023-2030
4.2.3 By Type - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
4.3 By Type - Global Recombinant Human Erythropoietin Injection Sales & Forecasts
4.3.1 By Type - Global Recombinant Human Erythropoietin Injection Sales, 2018-2023
4.3.2 By Type - Global Recombinant Human Erythropoietin Injection Sales, 2023-2030
4.3.3 By Type - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
4.4 By Type - Global Recombinant Human Erythropoietin Injection Price (Manufacturers Selling Prices), 2018-2030
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Erythropoietin Injection Market Size, 2022 & 2030
5.1.2 Renal Failure Anemia
5.1.3 Non Renal Anemia
5.2 By Application - Global Recombinant Human Erythropoietin Injection Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Erythropoietin Injection Revenue, 2018-2023
5.2.2 By Application - Global Recombinant Human Erythropoietin Injection Revenue, 2023-2030
5.2.3 By Application - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
5.3 By Application - Global Recombinant Human Erythropoietin Injection Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Erythropoietin Injection Sales, 2018-2023
5.3.2 By Application - Global Recombinant Human Erythropoietin Injection Sales, 2023-2030
5.3.3 By Application - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
5.4 By Application - Global Recombinant Human Erythropoietin Injection Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Recombinant Human Erythropoietin Injection Market Size, 2022 & 2030
6.2 By Region - Global Recombinant Human Erythropoietin Injection Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Erythropoietin Injection Revenue, 2018-2023
6.2.2 By Region - Global Recombinant Human Erythropoietin Injection Revenue, 2023-2030
6.2.3 By Region - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
6.3 By Region - Global Recombinant Human Erythropoietin Injection Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Erythropoietin Injection Sales, 2018-2023
6.3.2 By Region - Global Recombinant Human Erythropoietin Injection Sales, 2023-2030
6.3.3 By Region - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Recombinant Human Erythropoietin Injection Revenue, 2018-2030
6.4.2 By Country - North America Recombinant Human Erythropoietin Injection Sales, 2018-2030
6.4.3 US Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.4.4 Canada Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.4.5 Mexico Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Erythropoietin Injection Revenue, 2018-2030
6.5.2 By Country - Europe Recombinant Human Erythropoietin Injection Sales, 2018-2030
6.5.3 Germany Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.4 France Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.5 U.K. Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.6 Italy Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.7 Russia Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.8 Nordic Countries Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.5.9 Benelux Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Erythropoietin Injection Revenue, 2018-2030
6.6.2 By Region - Asia Recombinant Human Erythropoietin Injection Sales, 2018-2030
6.6.3 China Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.6.4 Japan Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.6.5 South Korea Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.6.6 Southeast Asia Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.6.7 India Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Recombinant Human Erythropoietin Injection Revenue, 2018-2030
6.7.2 By Country - South America Recombinant Human Erythropoietin Injection Sales, 2018-2030
6.7.3 Brazil Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.7.4 Argentina Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Sales, 2018-2030
6.8.3 Turkey Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.8.4 Israel Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.8.5 Saudi Arabia Recombinant Human Erythropoietin Injection Market Size, 2018-2030
6.8.6 UAE Recombinant Human Erythropoietin Injection Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Recombinant Human Erythropoietin Injection Major Product Offerings
7.1.4 Roche Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News
7.2 LG Chem
7.2.1 LG Chem Corporate Summary
7.2.2 LG Chem Business Overview
7.2.3 LG Chem Recombinant Human Erythropoietin Injection Major Product Offerings
7.2.4 LG Chem Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.2.5 LG Chem Key News
7.3 Kexing Biopharm
7.3.1 Kexing Biopharm Corporate Summary
7.3.2 Kexing Biopharm Business Overview
7.3.3 Kexing Biopharm Recombinant Human Erythropoietin Injection Major Product Offerings
7.3.4 Kexing Biopharm Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.3.5 Kexing Biopharm Key News
7.4 3SBio Group
7.4.1 3SBio Group Corporate Summary
7.4.2 3SBio Group Business Overview
7.4.3 3SBio Group Recombinant Human Erythropoietin Injection Major Product Offerings
7.4.4 3SBio Group Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.4.5 3SBio Group Key News
7.5 Harbin Pharmaceutical Group Holding
7.5.1 Harbin Pharmaceutical Group Holding Corporate Summary
7.5.2 Harbin Pharmaceutical Group Holding Business Overview
7.5.3 Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Major Product Offerings
7.5.4 Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.5.5 Harbin Pharmaceutical Group Holding Key News
7.6 Dong-E-E-Jiao
7.6.1 Dong-E-E-Jiao Corporate Summary
7.6.2 Dong-E-E-Jiao Business Overview
7.6.3 Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Major Product Offerings
7.6.4 Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.6.5 Dong-E-E-Jiao Key News
7.7 Humanwell Healthcare
7.7.1 Humanwell Healthcare Corporate Summary
7.7.2 Humanwell Healthcare Business Overview
7.7.3 Humanwell Healthcare Recombinant Human Erythropoietin Injection Major Product Offerings
7.7.4 Humanwell Healthcare Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.7.5 Humanwell Healthcare Key News
7.8 Ncpc Genetech Biotechnology
7.8.1 Ncpc Genetech Biotechnology Corporate Summary
7.8.2 Ncpc Genetech Biotechnology Business Overview
7.8.3 Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Major Product Offerings
7.8.4 Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.8.5 Ncpc Genetech Biotechnology Key News
7.9 Shandong E-hua Biotech Pharmaceutical
7.9.1 Shandong E-hua Biotech Pharmaceutical Corporate Summary
7.9.2 Shandong E-hua Biotech Pharmaceutical Business Overview
7.9.3 Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Major Product Offerings
7.9.4 Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.9.5 Shandong E-hua Biotech Pharmaceutical Key News
7.10 Intas Pharmaceuticals
7.10.1 Intas Pharmaceuticals Corporate Summary
7.10.2 Intas Pharmaceuticals Business Overview
7.10.3 Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Major Product Offerings
7.10.4 Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.10.5 Intas Pharmaceuticals Key News
7.11 PeproTech
7.11.1 PeproTech Corporate Summary
7.11.2 PeproTech Recombinant Human Erythropoietin Injection Business Overview
7.11.3 PeproTech Recombinant Human Erythropoietin Injection Major Product Offerings
7.11.4 PeproTech Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.11.5 PeproTech Key News
7.12 WELLONA PHARMA
7.12.1 WELLONA PHARMA Corporate Summary
7.12.2 WELLONA PHARMA Recombinant Human Erythropoietin Injection Business Overview
7.12.3 WELLONA PHARMA Recombinant Human Erythropoietin Injection Major Product Offerings
7.12.4 WELLONA PHARMA Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.12.5 WELLONA PHARMA Key News
7.13 SI HUAN SHENG WU
7.13.1 SI HUAN SHENG WU Corporate Summary
7.13.2 SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Business Overview
7.13.3 SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Major Product Offerings
7.13.4 SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.13.5 SI HUAN SHENG WU Key News
7.14 Shanxi Weiqidaguangming Pharmaceutical
7.14.1 Shanxi Weiqidaguangming Pharmaceutical Corporate Summary
7.14.2 Shanxi Weiqidaguangming Pharmaceutical Business Overview
7.14.3 Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Major Product Offerings
7.14.4 Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Sales and Revenue in Global (2018-2023)
7.14.5 Shanxi Weiqidaguangming Pharmaceutical Key News
8 Global Recombinant Human Erythropoietin Injection Production Capacity, Analysis
8.1 Global Recombinant Human Erythropoietin Injection Production Capacity, 2018-2030
8.2 Recombinant Human Erythropoietin Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Erythropoietin Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Erythropoietin Injection Supply Chain Analysis
10.1 Recombinant Human Erythropoietin Injection Industry Value Chain
10.2 Recombinant Human Erythropoietin Injection Upstream Market
10.3 Recombinant Human Erythropoietin Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Erythropoietin Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Human Erythropoietin Injection in Global Market
Table 2. Top Recombinant Human Erythropoietin Injection Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Recombinant Human Erythropoietin Injection Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Recombinant Human Erythropoietin Injection Revenue Share by Companies, 2018-2023
Table 5. Global Recombinant Human Erythropoietin Injection Sales by Companies, (K Units), 2018-2023
Table 6. Global Recombinant Human Erythropoietin Injection Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Recombinant Human Erythropoietin Injection Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Human Erythropoietin Injection Product Type
Table 9. List of Global Tier 1 Recombinant Human Erythropoietin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Erythropoietin Injection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2023-2030
Table 14. By Type - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2018-2023
Table 15. By Type - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2023-2030
Table 16. By Application ? Global Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2023-2030
Table 19. By Application - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2018-2023
Table 20. By Application - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2023-2030
Table 21. By Region ? Global Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Recombinant Human Erythropoietin Injection Revenue (US$, Mn), 2023-2030
Table 24. By Region - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2018-2023
Table 25. By Region - Global Recombinant Human Erythropoietin Injection Sales (K Units), 2023-2030
Table 26. By Country - North America Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2023-2030
Table 28. By Country - North America Recombinant Human Erythropoietin Injection Sales, (K Units), 2018-2023
Table 29. By Country - North America Recombinant Human Erythropoietin Injection Sales, (K Units), 2023-2030
Table 30. By Country - Europe Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2023-2030
Table 32. By Country - Europe Recombinant Human Erythropoietin Injection Sales, (K Units), 2018-2023
Table 33. By Country - Europe Recombinant Human Erythropoietin Injection Sales, (K Units), 2023-2030
Table 34. By Region - Asia Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2023-2030
Table 36. By Region - Asia Recombinant Human Erythropoietin Injection Sales, (K Units), 2018-2023
Table 37. By Region - Asia Recombinant Human Erythropoietin Injection Sales, (K Units), 2023-2030
Table 38. By Country - South America Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2023-2030
Table 40. By Country - South America Recombinant Human Erythropoietin Injection Sales, (K Units), 2018-2023
Table 41. By Country - South America Recombinant Human Erythropoietin Injection Sales, (K Units), 2023-2030
Table 42. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2023-2030
Table 44. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Sales, (K Units), 2023-2030
Table 46. Roche Corporate Summary
Table 47. Roche Recombinant Human Erythropoietin Injection Product Offerings
Table 48. Roche Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. LG Chem Corporate Summary
Table 50. LG Chem Recombinant Human Erythropoietin Injection Product Offerings
Table 51. LG Chem Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 52. Kexing Biopharm Corporate Summary
Table 53. Kexing Biopharm Recombinant Human Erythropoietin Injection Product Offerings
Table 54. Kexing Biopharm Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 55. 3SBio Group Corporate Summary
Table 56. 3SBio Group Recombinant Human Erythropoietin Injection Product Offerings
Table 57. 3SBio Group Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 58. Harbin Pharmaceutical Group Holding Corporate Summary
Table 59. Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Product Offerings
Table 60. Harbin Pharmaceutical Group Holding Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Dong-E-E-Jiao Corporate Summary
Table 62. Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Product Offerings
Table 63. Dong-E-E-Jiao Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 64. Humanwell Healthcare Corporate Summary
Table 65. Humanwell Healthcare Recombinant Human Erythropoietin Injection Product Offerings
Table 66. Humanwell Healthcare Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 67. Ncpc Genetech Biotechnology Corporate Summary
Table 68. Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Product Offerings
Table 69. Ncpc Genetech Biotechnology Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 70. Shandong E-hua Biotech Pharmaceutical Corporate Summary
Table 71. Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Product Offerings
Table 72. Shandong E-hua Biotech Pharmaceutical Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Intas Pharmaceuticals Corporate Summary
Table 74. Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Product Offerings
Table 75. Intas Pharmaceuticals Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 76. PeproTech Corporate Summary
Table 77. PeproTech Recombinant Human Erythropoietin Injection Product Offerings
Table 78. PeproTech Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 79. WELLONA PHARMA Corporate Summary
Table 80. WELLONA PHARMA Recombinant Human Erythropoietin Injection Product Offerings
Table 81. WELLONA PHARMA Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 82. SI HUAN SHENG WU Corporate Summary
Table 83. SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Product Offerings
Table 84. SI HUAN SHENG WU Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Shanxi Weiqidaguangming Pharmaceutical Corporate Summary
Table 86. Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Product Offerings
Table 87. Shanxi Weiqidaguangming Pharmaceutical Recombinant Human Erythropoietin Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 88. Recombinant Human Erythropoietin Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2023 (K Units)
Table 89. Global Recombinant Human Erythropoietin Injection Capacity Market Share of Key Manufacturers, 2020-2023
Table 90. Global Recombinant Human Erythropoietin Injection Production by Region, 2018-2023 (K Units)
Table 91. Global Recombinant Human Erythropoietin Injection Production by Region, 2023-2030 (K Units)
Table 92. Recombinant Human Erythropoietin Injection Market Opportunities & Trends in Global Market
Table 93. Recombinant Human Erythropoietin Injection Market Drivers in Global Market
Table 94. Recombinant Human Erythropoietin Injection Market Restraints in Global Market
Table 95. Recombinant Human Erythropoietin Injection Raw Materials
Table 96. Recombinant Human Erythropoietin Injection Raw Materials Suppliers in Global Market
Table 97. Typical Recombinant Human Erythropoietin Injection Downstream
Table 98. Recombinant Human Erythropoietin Injection Downstream Clients in Global Market
Table 99. Recombinant Human Erythropoietin Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Human Erythropoietin Injection Segment by Type
Figure 2. Recombinant Human Erythropoietin Injection Segment by Application
Figure 3. Global Recombinant Human Erythropoietin Injection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Erythropoietin Injection Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Human Erythropoietin Injection Revenue, 2018-2030 (US$, Mn)
Figure 7. Recombinant Human Erythropoietin Injection Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Erythropoietin Injection Revenue in 2022
Figure 9. By Type - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 10. By Type - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 11. By Type - Global Recombinant Human Erythropoietin Injection Price (US$/Unit), 2018-2030
Figure 12. By Application - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 13. By Application - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 14. By Application - Global Recombinant Human Erythropoietin Injection Price (US$/Unit), 2018-2030
Figure 15. By Region - Global Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 16. By Region - Global Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 17. By Country - North America Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 18. By Country - North America Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 19. US Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 20. Canada Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 21. Mexico Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 22. By Country - Europe Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 23. By Country - Europe Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 24. Germany Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 25. France Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 26. U.K. Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 27. Italy Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 28. Russia Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 29. Nordic Countries Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 30. Benelux Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 31. By Region - Asia Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 32. By Region - Asia Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 33. China Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 34. Japan Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 35. South Korea Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 36. Southeast Asia Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 37. India Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 38. By Country - South America Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 39. By Country - South America Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 40. Brazil Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 41. Argentina Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Revenue Market Share, 2018-2030
Figure 43. By Country - Middle East & Africa Recombinant Human Erythropoietin Injection Sales Market Share, 2018-2030
Figure 44. Turkey Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 45. Israel Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 46. Saudi Arabia Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 47. UAE Recombinant Human Erythropoietin Injection Revenue, (US$, Mn), 2018-2030
Figure 48. Global Recombinant Human Erythropoietin Injection Production Capacity (K Units), 2018-2030
Figure 49. The Percentage of Production Recombinant Human Erythropoietin Injection by Region, 2022 VS 2030
Figure 50. Recombinant Human Erythropoietin Injection Industry Value Chain
Figure 51. Marketing Channels
